Skip to main content
Premium Trial:

Request an Annual Quote

Coronavirus Test From DiaSorin Molecular Gets FDA Emergency Use Authorization

NEW YORK – An assay from DiaSorin Molecular to detect SARS-CoV-2, the virus that causes COVID-19, has been granted Emergency Use Authorization by the US Food and Drug Administration, the company said on Friday.

The test, called the Simplexa COVID-19 Direct assay, runs on DiaSorin's sample-to-answer Liason MDX real-time PCR instrument. It is intended to qualitatively detect nucleic acid from SARS-CoV-2 in nasopharyngeal swabs from individuals suspected of COVID-19 by their healthcare provider.

The Liason MDX can be used in two configurations. An eight-well direct amplification disc can be used for sample-to-answer testing, while a 96-well Universal Disc is designed for higher-volume testing. The discs require small volumes of sample and the instrument can perform both IVD as well as laboratory-developed tests.

Last week, DiaSorin was awarded $679,000 to further the development of its COVID-19 assay from US Department of Health and Human Services Office of the Assistant Secretary for Preparedness and Response's Biomedical Advanced Research and Development Authority, or BARDA, through its EZ-BAA process.

DiaSorin's test was granted EUA on Thursday, as was a test from GenMark. The list of COVID-19 tests with EUA now includes these as well as Roche, Thermo Fisher, Hologic, Quidel, and Abbott.

The Scan

Harvard Team Report One-Time Base Editing Treatment for Motor Neuron Disease in Mice

A base-editing approach restored SMN levels and improved motor function in a mouse model of spinal muscular atrophy, a new Science paper reports.

International Team Examines History of North American Horses

Genetic and other analyses presented in Science find that horses spread to the northern Rockies and Great Plains by the first half of the 17th century.

New Study Examines Genetic Dominance Within UK Biobank

Researchers analyze instances of genetic dominance within UK Biobank data, as they report in Science.

Cell Signaling Pathway Identified as Metastasis Suppressor

A new study in Nature homes in on the STING pathway as a suppressor of metastasis in a mouse model of lung cancer.